We have synthesized 8-methoxy-2-( N-2′-chloropropyl, N-propyl) aminotetralin (8-methoxy-2′-chloro-PAT), an alkylating agent derived from the potent 5-HT agonist, 8-hydroxy-2-( N, N-dipropyl)-aminotetralin (PAT). As expected for an irreversible ligand, the blockade of 3H-PAT or 3H-5-HT binding to post-synaptic 5-HT 1 (A and B) sites in rat hippocampal membranes pretreated with 8-methoxy-2′-chloro-PAT could not be prevented by extensive washing of membranes. Prior occupancy of 5-HT 1 sites by 5-HT or PAT prevented any subsequent irreversible blockade by the alkylating agent. Similar irreversible blockade by 8-methoxy-2′-chloro-PAT was found on 3H-PAT binding to striatal membranes suggesting that presynaptic 5-HT binding sites (see Gozlan et al., Nature, Lond. 305, 140, 1983) were sensitive also to the alkylating agent. In contrast, the modifying agent N-ethylmaleimide (NEM) reduced markedly 3H-PAT binding to postsynaptic hippocampal 5-HT 1 sites, but did not alter 3H-PAT binding to striatal presynaptic 5-HT sites. Although 8-methoxy-2′-chloro-PAT bound irreversibly to different classes of 5-HT binding sites (5-HT 1A, 5-HT 1B, presynaptic sites), it can be considered a selective alkylating agent, since it exerted no action on 3H-spiperone binding to 5-HT 2 sites, 3H-muscimol binding to GABA sites, or 3H-flunitrazepam binding to benzodiazepine sites.